Nan S. Wong
Mount Elizabeth Novena Medical Centre
Singapore, Singapore
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrence.
Journal: NPJ breast cancer
Published: December 03, 2025
Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations.
Journal: Clinical pharmacology and therapeutics
Published: October 28, 2022
Primary medical therapy and breast conservation treatment: the medical oncology perspective.
Journal: Gland surgery
Published: January 29, 2019
Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.
Journal: JAMA oncology
Published: July 18, 2017
Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients.
Journal: Clinical pharmacokinetics
Published: April 22, 2016
Association of CYP2C19*2 and associated haplotypes with lower norendoxifen concentrations in tamoxifen-treated Asian breast cancer patients.
Journal: British journal of clinical pharmacology
Published: August 27, 2015
Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients.
Journal: The pharmacogenomics journal
Published: August 03, 2015
Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.
Journal: The pharmacogenomics journal
Published: February 04, 2014
Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab.
Journal: Cancer medicine
Published: December 18, 2012
ETV6 disruption does not predict indolent clinical behavior in secretory breast carcinoma.
Journal: The breast journal
Published: October 20, 2012
Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group's 5-dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy-Breast (FACT-B), in Asian breast cancer patients.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: October 03, 2012
Last Updated: 09/26/2026